Abstract
Breast cancer has a high worldwide prevalence and is the leading cause of cancer-related death among women. The treatment approach depends on the tumor's molecular subtype (luminal A, luminal B, HER2, and triple-negative) and may include surgical procedures, radiotherapy, and systemic therapy. Despite advances in systemic treatments over recent decades, the development of adverse effects …